- {{heading}}
- Ab04318-23.0 Anti-Ca 19-9 [121SLE]
- Human
- Rabbit IgG
- Purified
- Ships in 5-6 weeks
- Ab04318-21.0 Anti-Ca 19-9 [121SLE]
- Human
- Mouse IgM
- Purified
- Ships in 5-6 weeks
Recombinant monoclonal antibody to Ca 19-9. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 121SLE.
Alternative Name(s) of Target: 121 SLE; sialyl Lewis a
Immunogen: The original antibody was raised by immunizing a mouse with ten precipitin lines obtained after immunodiffusion using monoclonal antibody NS 19-9 and mucins isolated from an ovarian cyst of a OLe (a+b-) patient.
Specificity: This antibody is specific for CA19-9.
Application Notes: The original version of this antibody was used for immunohistochemistry on the normal gastrointestinal mucosa of Le-positive individuals (Herrero-Zabaleta et al., 1987; PMID:2444292), and on endometrial tissue specimens obtained in different phases of the menstrual cycle (Hey and Aplin., 1996; PMID:8910004). This antibody was used for an ELISA on carbohydrate proteins (Manimala et al., 2007; PMID:17483136), and on MUC1 samples (Hey and Aplin., 1996; PMID:8910004). Furthermore this antibody was used for immunocytochemistry on HT 29 tumour cells (Köhler et al., 2009; PMID:20010946). The original version of this antibody was used for flow cytometry on ovarian cancer cell line SW626 and SCLC cell line DMS79 (Ragupathi et al., 2009; PMID:19190907).
Antibody first published in:
Herrero-Zabaleta et al. Monoclonal antibody against sialylated Lewis(a) antigen Bull Cancer. 1987;74(4):387-96. PMID:2444292
Note on publication:
The original paper isolated hybridoma cells, which secreted monoclonal antibody (MAb) 121 SLE.